Global Injectable Drug Delivery Market by Therapeutic Use (Hormonal Disorders, Autoimmune Disorders, Oncology), by Device Type (Self-injection Devices, Conventional Devices), by Formulation (Novel Drug Delivery, Conventional Drug Delivery) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Industry Insights
Injectable drug delivery (IDD), was valued at USD 331.0 million in 2015. The demand for drug delivery systems has increased significantly due to an increase in chronic diseases such as cancer and diabetes. Injectables are being used to treat a growing number of diseases such as Wilson's, autoimmune diseases and cystic fibrosis. These drugs can be administered to patients who are unconscious or comatose and they are preferred over other methods of drug delivery.
Technological advances have allowed for the creation of new and improved devices as well as equipment tailored to specific patient care needs. Technological innovations such as dual-injectables, which allow for drug delivery via injectables, have also enhanced their effectiveness. The development of the biologics industry has led to increased demand for these injectables. These significant changes are driving market growth.
Market for injectable drugs delivery, by devices, 2013, 2024 (USD million)
This market is severely restricted by injuries and infections caused by needles in syringes. Contaminations from previously administered injectables or needle-stick injuries can cause serious complications that require further treatment. These complications often create additional hurdles in managing the disease. Oral administration of drugs is preferred to injections in certain instances because they are less toxic. IDD forms are also discouraged by strict regulatory restrictions. There have been many concerns in recent years about the safety of injectables. This has resulted in a decrease in approved production facilities and a consequent shortage of these drugs on the market. Despite these limitations, IDD has enormous market potential due to its many benefits and wide application in a variety of conditions. Many major companies are also contributing to this market by embracing injectables and substituting oral dosages.
Product Insights
The market can be divided into two types based on product: devices and formulations. The devices segment can be further divided into conventional injection devices and self-injection device. The self-injection devices include needle-free injectors and auto-injectors as well pen injectors.
The IDD market can be divided by formulations into novel drug delivery and conventional drug delivery. Solutions, reconstituted/lyophilized formulations and suspensions are all examples of conventional drug delivery systems. Emulsions are another example. Colloidal dispersions are colloidal particles, which can be liposomes or niosomes as well as polymeric or mixed micelles and nanoparticles. These microparticles can be used to absorb drugs quickly at their intended sites. The use of colloidal dispersions for drug delivery systems has increased significantly as a result of large investments by most companies in R&D.
The fastest-growing segment of this market is the one that includes self-injection devices. These devices make it easier to manage and control various disorders at primary level. Innovative technology allows painless administration of pharmaceutical drugs with needle-free injectors. This segment is one of the fastest growing and most profitable.
Therapeutic Use
The therapeutic use segmentation of the industry can be broken down into auto-immune diseases, hormonal disorders, cancer, and other segments. IDD devices are used extensively in diabetes and oncology care. IDD devices are used extensively in chemotherapy for oncological conditions. Diabetes care, on the other hand, requires the administration of insulin. This is accomplished with the help of auto-injectors and pen-injectors as well as needle-free injectors.
End-User Application Information
The market can be divided into home care settings and hospitals based on end-user applications. Other end-user applications include research institutes, clinics, and diagnostic labs. The advent of self-injection devices such as pen-injectors and auto-injectors has made administering IDD relatively simple. This allows patients to do their own drug administration at home, without the need for medical assistance. The majority of market leaders have launched devices that allow the administration of insulin using self-injection devices due to the rising number of diabetes patients. In 2015, home care settings was the most lucrative segment in the market.
Regional Insights
This report focuses on the U.S., Canada, Germany and U.K. as well as South Africa, Saudi Arabia and Brazil. Technology is more advanced in North America than it is elsewhere, making it easier to serve a large population. This region has a high prevalence of chronic diseases, which means that it is imperative to create newer and more effective drug delivery systems.
China and India dominate Asia's market. They offer a wide range of products with specific modifications to meet the needs of their patients. The need for IDD systems is growing because of the large Asian population.
Insights from the Competitive Market
Companies like Pfizer, Inc., Baxter International, Inc., Terumo Corporation, Becton, Dickinson and Company, Schott AG, and others are key players in the market. Certain products have been consolidated by some of the market's major players to make it easier for manufacturing and distribution.
Up Market Research published a new report titled “Injectable Drug Delivery Market research report which is segmented by Therapeutic Use (Hormonal Disorders, Autoimmune Disorders, Oncology), by Device Type (Self-injection Devices, Conventional Devices), by Formulation (Novel Drug Delivery, Conventional Drug Delivery), By Players/Companies Terumo Corporation, Inc, Baxter International, Inc, companies like Pfizer, Becton, Dickinson and Company, Schott AG among others Some of the major players in the market have consolidated partnerships for certain products that allow for ease of manufacturing and distribution”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Injectable Drug Delivery Market Research Report |
| By Therapeutic Use | Hormonal Disorders, Autoimmune Disorders, Oncology |
| By Device Type | Self-injection Devices, Conventional Devices |
| By Formulation | Novel Drug Delivery, Conventional Drug Delivery |
| By Companies | Terumo Corporation, Inc, Baxter International, Inc, companies like Pfizer, Becton, Dickinson and Company, Schott AG among others Some of the major players in the market have consolidated partnerships for certain products that allow for ease of manufacturing and distribution |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 228 |
| Number of Tables & Figures | 160 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Injectable Drug Delivery Market Report Segments:
The market is segmented by Therapeutic Use (Hormonal Disorders, Autoimmune Disorders, Oncology), by Device Type (Self-injection Devices, Conventional Devices), by Formulation (Novel Drug Delivery, Conventional Drug Delivery).
Injectable Drug Delivery Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Injectable Drug Delivery Market
Overview of the regional outlook of the Injectable Drug Delivery Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Injectable Drug Delivery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Injectable Drug Delivery Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Hormonal Disorders
2. Autoimmune Disorders
3. Oncology
7. By Device Type:1. Self-injection Devices
2. Conventional Devices
8. By Formulation:1. Novel Drug Delivery
2. Conventional Drug Delivery
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Injectable Drug Delivery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Injectable Drug Delivery Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Injectable Drug Delivery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Injectable Drug Delivery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Injectable Drug Delivery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Injectable Drug Delivery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Injectable Drug Delivery Market Size & Forecast, 2018-2028
4.5.1 Injectable Drug Delivery Market Size and Y-o-Y Growth
4.5.2 Injectable Drug Delivery Market Absolute $ Opportunity
Chapter 5 Global Injectable Drug Delivery Market Analysis and Forecast by Therapeutic Use
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Therapeutic Use
5.1.2 Basis Point Share (BPS) Analysis by Therapeutic Use
5.1.3 Absolute $ Opportunity Assessment by Therapeutic Use
5.2 Injectable Drug Delivery Market Size Forecast by Therapeutic Use
5.2.1 Hormonal Disorders
5.2.2 Autoimmune Disorders
5.2.3 Oncology
5.3 Market Attractiveness Analysis by Therapeutic Use
Chapter 6 Global Injectable Drug Delivery Market Analysis and Forecast by Device Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Device Type
6.1.2 Basis Point Share (BPS) Analysis by Device Type
6.1.3 Absolute $ Opportunity Assessment by Device Type
6.2 Injectable Drug Delivery Market Size Forecast by Device Type
6.2.1 Self-injection Devices
6.2.2 Conventional Devices
6.3 Market Attractiveness Analysis by Device Type
Chapter 7 Global Injectable Drug Delivery Market Analysis and Forecast by Formulation
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Formulation
7.1.2 Basis Point Share (BPS) Analysis by Formulation
7.1.3 Absolute $ Opportunity Assessment by Formulation
7.2 Injectable Drug Delivery Market Size Forecast by Formulation
7.2.1 Novel Drug Delivery
7.2.2 Conventional Drug Delivery
7.3 Market Attractiveness Analysis by Formulation
Chapter 8 Global Injectable Drug Delivery Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Injectable Drug Delivery Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America Injectable Drug Delivery Analysis and Forecast
10.1 Introduction
10.2 North America Injectable Drug Delivery Market Size Forecast by Country
10.2.1 U.S.
10.2.2 Canada
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America Injectable Drug Delivery Market Size Forecast by Therapeutic Use
10.6.1 Hormonal Disorders
10.6.2 Autoimmune Disorders
10.6.3 Oncology
10.7 Basis Point Share (BPS) Analysis by Therapeutic Use
10.8 Absolute $ Opportunity Assessment by Therapeutic Use
10.9 Market Attractiveness Analysis by Therapeutic Use
10.10 North America Injectable Drug Delivery Market Size Forecast by Device Type
10.10.1 Self-injection Devices
10.10.2 Conventional Devices
10.11 Basis Point Share (BPS) Analysis by Device Type
10.12 Absolute $ Opportunity Assessment by Device Type
10.13 Market Attractiveness Analysis by Device Type
10.14 North America Injectable Drug Delivery Market Size Forecast by Formulation
10.14.1 Novel Drug Delivery
10.14.2 Conventional Drug Delivery
10.15 Basis Point Share (BPS) Analysis by Formulation
10.16 Absolute $ Opportunity Assessment by Formulation
10.17 Market Attractiveness Analysis by Formulation
Chapter 11 Europe Injectable Drug Delivery Analysis and Forecast
11.1 Introduction
11.2 Europe Injectable Drug Delivery Market Size Forecast by Country
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 U.K.
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe Injectable Drug Delivery Market Size Forecast by Therapeutic Use
11.6.1 Hormonal Disorders
11.6.2 Autoimmune Disorders
11.6.3 Oncology
11.7 Basis Point Share (BPS) Analysis by Therapeutic Use
11.8 Absolute $ Opportunity Assessment by Therapeutic Use
11.9 Market Attractiveness Analysis by Therapeutic Use
11.10 Europe Injectable Drug Delivery Market Size Forecast by Device Type
11.10.1 Self-injection Devices
11.10.2 Conventional Devices
11.11 Basis Point Share (BPS) Analysis by Device Type
11.12 Absolute $ Opportunity Assessment by Device Type
11.13 Market Attractiveness Analysis by Device Type
11.14 Europe Injectable Drug Delivery Market Size Forecast by Formulation
11.14.1 Novel Drug Delivery
11.14.2 Conventional Drug Delivery
11.15 Basis Point Share (BPS) Analysis by Formulation
11.16 Absolute $ Opportunity Assessment by Formulation
11.17 Market Attractiveness Analysis by Formulation
Chapter 12 Asia Pacific Injectable Drug Delivery Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific Injectable Drug Delivery Market Size Forecast by Country
12.2.1 China
12.2.2 Japan
12.2.3 South Korea
12.2.4 India
12.2.5 Australia
12.2.6 South East Asia (SEA)
12.2.7 Rest of Asia Pacific (APAC)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific Injectable Drug Delivery Market Size Forecast by Therapeutic Use
12.6.1 Hormonal Disorders
12.6.2 Autoimmune Disorders
12.6.3 Oncology
12.7 Basis Point Share (BPS) Analysis by Therapeutic Use
12.8 Absolute $ Opportunity Assessment by Therapeutic Use
12.9 Market Attractiveness Analysis by Therapeutic Use
12.10 Asia Pacific Injectable Drug Delivery Market Size Forecast by Device Type
12.10.1 Self-injection Devices
12.10.2 Conventional Devices
12.11 Basis Point Share (BPS) Analysis by Device Type
12.12 Absolute $ Opportunity Assessment by Device Type
12.13 Market Attractiveness Analysis by Device Type
12.14 Asia Pacific Injectable Drug Delivery Market Size Forecast by Formulation
12.14.1 Novel Drug Delivery
12.14.2 Conventional Drug Delivery
12.15 Basis Point Share (BPS) Analysis by Formulation
12.16 Absolute $ Opportunity Assessment by Formulation
12.17 Market Attractiveness Analysis by Formulation
Chapter 13 Latin America Injectable Drug Delivery Analysis and Forecast
13.1 Introduction
13.2 Latin America Injectable Drug Delivery Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America Injectable Drug Delivery Market Size Forecast by Therapeutic Use
13.6.1 Hormonal Disorders
13.6.2 Autoimmune Disorders
13.6.3 Oncology
13.7 Basis Point Share (BPS) Analysis by Therapeutic Use
13.8 Absolute $ Opportunity Assessment by Therapeutic Use
13.9 Market Attractiveness Analysis by Therapeutic Use
13.10 Latin America Injectable Drug Delivery Market Size Forecast by Device Type
13.10.1 Self-injection Devices
13.10.2 Conventional Devices
13.11 Basis Point Share (BPS) Analysis by Device Type
13.12 Absolute $ Opportunity Assessment by Device Type
13.13 Market Attractiveness Analysis by Device Type
13.14 Latin America Injectable Drug Delivery Market Size Forecast by Formulation
13.14.1 Novel Drug Delivery
13.14.2 Conventional Drug Delivery
13.15 Basis Point Share (BPS) Analysis by Formulation
13.16 Absolute $ Opportunity Assessment by Formulation
13.17 Market Attractiveness Analysis by Formulation
Chapter 14 Middle East & Africa (MEA) Injectable Drug Delivery Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) Injectable Drug Delivery Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) Injectable Drug Delivery Market Size Forecast by Therapeutic Use
14.6.1 Hormonal Disorders
14.6.2 Autoimmune Disorders
14.6.3 Oncology
14.7 Basis Point Share (BPS) Analysis by Therapeutic Use
14.8 Absolute $ Opportunity Assessment by Therapeutic Use
14.9 Market Attractiveness Analysis by Therapeutic Use
14.10 Middle East & Africa (MEA) Injectable Drug Delivery Market Size Forecast by Device Type
14.10.1 Self-injection Devices
14.10.2 Conventional Devices
14.11 Basis Point Share (BPS) Analysis by Device Type
14.12 Absolute $ Opportunity Assessment by Device Type
14.13 Market Attractiveness Analysis by Device Type
14.14 Middle East & Africa (MEA) Injectable Drug Delivery Market Size Forecast by Formulation
14.14.1 Novel Drug Delivery
14.14.2 Conventional Drug Delivery
14.15 Basis Point Share (BPS) Analysis by Formulation
14.16 Absolute $ Opportunity Assessment by Formulation
14.17 Market Attractiveness Analysis by Formulation
Chapter 15 Competition Landscape
15.1 Injectable Drug Delivery Market: Competitive Dashboard
15.2 Global Injectable Drug Delivery Market: Market Share Analysis, 2019
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 Terumo Corporation
15.3.2 Inc
15.3.3 Baxter International
15.3.4 Inc
15.3.5 companies like Pfizer
15.3.6 Becton
15.3.7 Dickinson and Company
15.3.8 Schott AG among others Some of the major players in the market have consolidated partnerships for certain products that allow for ease of manufacturing and distribution
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Injectable Drug Delivery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Injectable Drug Delivery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Injectable Drug Delivery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Injectable Drug Delivery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Injectable Drug Delivery Market Size & Forecast, 2018-2028
4.5.1 Injectable Drug Delivery Market Size and Y-o-Y Growth
4.5.2 Injectable Drug Delivery Market Absolute $ Opportunity
Chapter 5 Global Injectable Drug Delivery Market Analysis and Forecast by Therapeutic Use
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Therapeutic Use
5.1.2 Basis Point Share (BPS) Analysis by Therapeutic Use
5.1.3 Absolute $ Opportunity Assessment by Therapeutic Use
5.2 Injectable Drug Delivery Market Size Forecast by Therapeutic Use
5.2.1 Hormonal Disorders
5.2.2 Autoimmune Disorders
5.2.3 Oncology
5.3 Market Attractiveness Analysis by Therapeutic Use
Chapter 6 Global Injectable Drug Delivery Market Analysis and Forecast by Device Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Device Type
6.1.2 Basis Point Share (BPS) Analysis by Device Type
6.1.3 Absolute $ Opportunity Assessment by Device Type
6.2 Injectable Drug Delivery Market Size Forecast by Device Type
6.2.1 Self-injection Devices
6.2.2 Conventional Devices
6.3 Market Attractiveness Analysis by Device Type
Chapter 7 Global Injectable Drug Delivery Market Analysis and Forecast by Formulation
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Formulation
7.1.2 Basis Point Share (BPS) Analysis by Formulation
7.1.3 Absolute $ Opportunity Assessment by Formulation
7.2 Injectable Drug Delivery Market Size Forecast by Formulation
7.2.1 Novel Drug Delivery
7.2.2 Conventional Drug Delivery
7.3 Market Attractiveness Analysis by Formulation
Chapter 8 Global Injectable Drug Delivery Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Injectable Drug Delivery Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America Injectable Drug Delivery Analysis and Forecast
10.1 Introduction
10.2 North America Injectable Drug Delivery Market Size Forecast by Country
10.2.1 U.S.
10.2.2 Canada
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America Injectable Drug Delivery Market Size Forecast by Therapeutic Use
10.6.1 Hormonal Disorders
10.6.2 Autoimmune Disorders
10.6.3 Oncology
10.7 Basis Point Share (BPS) Analysis by Therapeutic Use
10.8 Absolute $ Opportunity Assessment by Therapeutic Use
10.9 Market Attractiveness Analysis by Therapeutic Use
10.10 North America Injectable Drug Delivery Market Size Forecast by Device Type
10.10.1 Self-injection Devices
10.10.2 Conventional Devices
10.11 Basis Point Share (BPS) Analysis by Device Type
10.12 Absolute $ Opportunity Assessment by Device Type
10.13 Market Attractiveness Analysis by Device Type
10.14 North America Injectable Drug Delivery Market Size Forecast by Formulation
10.14.1 Novel Drug Delivery
10.14.2 Conventional Drug Delivery
10.15 Basis Point Share (BPS) Analysis by Formulation
10.16 Absolute $ Opportunity Assessment by Formulation
10.17 Market Attractiveness Analysis by Formulation
Chapter 11 Europe Injectable Drug Delivery Analysis and Forecast
11.1 Introduction
11.2 Europe Injectable Drug Delivery Market Size Forecast by Country
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 U.K.
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe Injectable Drug Delivery Market Size Forecast by Therapeutic Use
11.6.1 Hormonal Disorders
11.6.2 Autoimmune Disorders
11.6.3 Oncology
11.7 Basis Point Share (BPS) Analysis by Therapeutic Use
11.8 Absolute $ Opportunity Assessment by Therapeutic Use
11.9 Market Attractiveness Analysis by Therapeutic Use
11.10 Europe Injectable Drug Delivery Market Size Forecast by Device Type
11.10.1 Self-injection Devices
11.10.2 Conventional Devices
11.11 Basis Point Share (BPS) Analysis by Device Type
11.12 Absolute $ Opportunity Assessment by Device Type
11.13 Market Attractiveness Analysis by Device Type
11.14 Europe Injectable Drug Delivery Market Size Forecast by Formulation
11.14.1 Novel Drug Delivery
11.14.2 Conventional Drug Delivery
11.15 Basis Point Share (BPS) Analysis by Formulation
11.16 Absolute $ Opportunity Assessment by Formulation
11.17 Market Attractiveness Analysis by Formulation
Chapter 12 Asia Pacific Injectable Drug Delivery Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific Injectable Drug Delivery Market Size Forecast by Country
12.2.1 China
12.2.2 Japan
12.2.3 South Korea
12.2.4 India
12.2.5 Australia
12.2.6 South East Asia (SEA)
12.2.7 Rest of Asia Pacific (APAC)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific Injectable Drug Delivery Market Size Forecast by Therapeutic Use
12.6.1 Hormonal Disorders
12.6.2 Autoimmune Disorders
12.6.3 Oncology
12.7 Basis Point Share (BPS) Analysis by Therapeutic Use
12.8 Absolute $ Opportunity Assessment by Therapeutic Use
12.9 Market Attractiveness Analysis by Therapeutic Use
12.10 Asia Pacific Injectable Drug Delivery Market Size Forecast by Device Type
12.10.1 Self-injection Devices
12.10.2 Conventional Devices
12.11 Basis Point Share (BPS) Analysis by Device Type
12.12 Absolute $ Opportunity Assessment by Device Type
12.13 Market Attractiveness Analysis by Device Type
12.14 Asia Pacific Injectable Drug Delivery Market Size Forecast by Formulation
12.14.1 Novel Drug Delivery
12.14.2 Conventional Drug Delivery
12.15 Basis Point Share (BPS) Analysis by Formulation
12.16 Absolute $ Opportunity Assessment by Formulation
12.17 Market Attractiveness Analysis by Formulation
Chapter 13 Latin America Injectable Drug Delivery Analysis and Forecast
13.1 Introduction
13.2 Latin America Injectable Drug Delivery Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America Injectable Drug Delivery Market Size Forecast by Therapeutic Use
13.6.1 Hormonal Disorders
13.6.2 Autoimmune Disorders
13.6.3 Oncology
13.7 Basis Point Share (BPS) Analysis by Therapeutic Use
13.8 Absolute $ Opportunity Assessment by Therapeutic Use
13.9 Market Attractiveness Analysis by Therapeutic Use
13.10 Latin America Injectable Drug Delivery Market Size Forecast by Device Type
13.10.1 Self-injection Devices
13.10.2 Conventional Devices
13.11 Basis Point Share (BPS) Analysis by Device Type
13.12 Absolute $ Opportunity Assessment by Device Type
13.13 Market Attractiveness Analysis by Device Type
13.14 Latin America Injectable Drug Delivery Market Size Forecast by Formulation
13.14.1 Novel Drug Delivery
13.14.2 Conventional Drug Delivery
13.15 Basis Point Share (BPS) Analysis by Formulation
13.16 Absolute $ Opportunity Assessment by Formulation
13.17 Market Attractiveness Analysis by Formulation
Chapter 14 Middle East & Africa (MEA) Injectable Drug Delivery Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) Injectable Drug Delivery Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) Injectable Drug Delivery Market Size Forecast by Therapeutic Use
14.6.1 Hormonal Disorders
14.6.2 Autoimmune Disorders
14.6.3 Oncology
14.7 Basis Point Share (BPS) Analysis by Therapeutic Use
14.8 Absolute $ Opportunity Assessment by Therapeutic Use
14.9 Market Attractiveness Analysis by Therapeutic Use
14.10 Middle East & Africa (MEA) Injectable Drug Delivery Market Size Forecast by Device Type
14.10.1 Self-injection Devices
14.10.2 Conventional Devices
14.11 Basis Point Share (BPS) Analysis by Device Type
14.12 Absolute $ Opportunity Assessment by Device Type
14.13 Market Attractiveness Analysis by Device Type
14.14 Middle East & Africa (MEA) Injectable Drug Delivery Market Size Forecast by Formulation
14.14.1 Novel Drug Delivery
14.14.2 Conventional Drug Delivery
14.15 Basis Point Share (BPS) Analysis by Formulation
14.16 Absolute $ Opportunity Assessment by Formulation
14.17 Market Attractiveness Analysis by Formulation
Chapter 15 Competition Landscape
15.1 Injectable Drug Delivery Market: Competitive Dashboard
15.2 Global Injectable Drug Delivery Market: Market Share Analysis, 2019
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 Terumo Corporation
15.3.2 Inc
15.3.3 Baxter International
15.3.4 Inc
15.3.5 companies like Pfizer
15.3.6 Becton
15.3.7 Dickinson and Company
15.3.8 Schott AG among others Some of the major players in the market have consolidated partnerships for certain products that allow for ease of manufacturing and distribution
Segments Covered in the Report
The global Injectable Drug Delivery market has been segmented based on
By Therapeutic Use
The global Injectable Drug Delivery market has been segmented based on
By Therapeutic Use
- Hormonal Disorders
- Autoimmune Disorders
- Oncology
- Self-injection Devices
- Conventional Devices
- Novel Drug Delivery
- Conventional Drug Delivery
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Terumo Corporation
- Inc
- Baxter International
- Inc
- companies like Pfizer
- Becton
- Dickinson and Company
- Schott AG among others Some of the major players in the market have consolidated partnerships for certain products that allow for ease of manufacturing and distribution
Our Clients
Related Reports
Some other reports from this category!
